Overview Cancer pain pump

What is targeted drug delivery?

Targeted drug delivery (TDD) provides effective pain relief by delivering medication directly to the fluid surrounding the spinal cord via a programmable pump.^1-5

• At 4 weeks, more patients receiving TDD  plus conventional medical management (CMM) reported a pain score less than 4 compared with those receiving CMM alone.¹ On a 0-10 pain scale, below 4 marks the point at which patients can assume more normal role function.¹
• 85% of patients receiving TDD and CMM reported at least 20% reduction in pain score or fewer side effects; 58% reported at least 20% relief and fewer side effects.¹
• At 6 months, patients providing baseline and follow-up data reported significant improvements in pain and quality of life compared to baseline.³
• At 4 weeks, 87.5% of patients were able to discontinue systemic opioids with TDD and 92% remained off systemic opioids at 8 weeks.⁴
• The number of patients with severe pain (≥7) related to pancreatic cancer decreased from 89.2% before TDD to 4.5% after 1 week, 6.7% after 1 month, and 10.3% after 3 months of pump implant.⁵

Targeted drug delivery is an option for cancer pain management and is commonly known as a “pain pump.”